Hansa Biopharma AB (HNSBF)

2.93 0.00 (0.00%) USD  |  OTCM  |  Sep 20, 16:00
More

Hansa Biopharma Price to Book Value

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2015. Upgrade now.
Date Value
September 26, 2023 12.34
September 25, 2023 12.34
September 22, 2023 12.34
September 21, 2023 12.34
September 20, 2023 12.34
September 19, 2023 12.34
September 18, 2023 12.34
September 15, 2023 12.34
September 14, 2023 12.34
September 13, 2023 12.34
September 12, 2023 12.34
September 11, 2023 12.34
September 08, 2023 12.34
September 07, 2023 12.34
September 06, 2023 12.34
September 05, 2023 12.34
September 01, 2023 12.34
August 31, 2023 12.34
August 30, 2023 12.34
August 29, 2023 12.34
August 21, 2023 14.93
August 18, 2023 14.93
August 17, 2023 14.93
August 16, 2023 14.93
August 15, 2023 14.93
Date Value
August 14, 2023 14.93
August 11, 2023 14.93
August 10, 2023 14.93
August 09, 2023 14.93
August 08, 2023 14.93
August 07, 2023 14.93
August 04, 2023 14.93
August 03, 2023 14.93
August 02, 2023 14.93
August 01, 2023 14.93
July 31, 2023 14.93
June 30, 2023
June 02, 2023 6.933
June 01, 2023 6.933
May 31, 2023 6.933
May 30, 2023 6.933
May 26, 2023 6.933
May 25, 2023 6.933
May 24, 2023 6.933
May 23, 2023 6.933
May 22, 2023 6.933
May 19, 2023 6.933
May 18, 2023 6.933
May 17, 2023 6.933
May 16, 2023 6.933

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

3.655
Minimum
May 03 2022
31.42
Maximum
Jul 27 2020
9.314
Average
6.933
Median
May 11 2023

Price to Book Value Benchmarks

Abliva AB 2.537
Karolinska Development AB 0.5993
Calliditas Therapeutics AB 109.01
Oncopeptides AB --
BioInvent International AB 2.991

Price to Book Value Related Metrics

PS Ratio 10.45
Price 2.93
Earnings Yield -46.86%
Market Cap 198.54M